Symptomatic dry eye treatment with autologous platelet-rich plasma

Ophthalmic Research

Volumn 39, Issue 3, 2007, Pages 124-129

  Alio, Jorge L ^a,b   Colecha, José R ^a   Pastor, Silvia ^a   Rodriguez, Alejandra ^a   Artola, Alberto ^a,b  

^a Instituto Oftalmologico de Alicante ^*  (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Autologous platelet rich plasma, topical eyedrops; Dry eye syndrome; Growth factors; Ocular surface inflammation

Indexed keywords

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONJUNCTIVAL HYPEREMIA; DRY EYE; FEMALE; FLUORESCENCE; HUMAN; IMPRESSION CYTOLOGY; INFLAMMATION; LACRIMAL FLUID; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; VISUAL ACUITY; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; CONJUNCTIVA; DRY EYE SYNDROMES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; PLATELET-RICH PLASMA; PROSPECTIVE STUDIES; TEARS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 34250652219     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100933     Document Type: Article

References (39)

1. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC: The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-589.
2. Mathers WD: Why the eye becomes dry: a cornea and lacrimal gland feedback model. CLAO J 2000;26:159-165.
3. Pflugfelder SC, Wilhelmus KR, Osato MS, Matoba AY, Font RL: The autoimmune nature of aqueous tear deficiency. Ophthalmology 1986;93:1513-1517.
4. Pepose JS, Akata RF, Pflugfelder SC, Voigt W: Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome. Ophthalmology 1990;97:1599-1605.
5. Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F: Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990;170:56-69.
6. Ernesto C: Growth factors and their potential clinical value. J Clin Endocrinol Metab 1992;75:1-4.
7. Lynch SE, Colvin RB, Antoniades HN: Growth factors in wound healing: single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest 1989;84:640-646.
8. Knighton DR, Hunt TK, Thakral KK, Goodson WH: Role of platelet and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982;196:379-388.
9. Ross R, Glomset J, Kariya B, Harker L: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-1210.
10. Antoniades HN, Scher CD, Stiles CD: Purification of human platelet-derived growth factor. Proc Natl Acad Sci USA 1979;76:1809-1813.
11. Marx RE: Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001;10:225-228.
12. Sammartino G, Tia M, Marenzi G, di Lauro AE, D'Agostino E, Claudio PP: Use of autologous platelet-rich plasma (PRP) in periodontal defect treatment after extraction of impacted mandibular third molars. J Oral Maxillofac Surg 2005;63:766-770.
13. Choi BH, Im CJ, Huh JY, Suh JJ, Lee SH : Effect of platelet-rich plasma on bone regeneration in autogenous bone graft. Int J Oral Maxillofac Surg 2004;33:56-59.
14. Alió JL, Artola A, Rodríguez-Prats JL, Pastor S, Ruiz-Colechá J: Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology, in press.
15. Alió JL, Pastor S, Ruiz-Colechá J, Rodríguez A, Artola A: Treatment of ocular surface syndrome (OSS) post-laser in situ keratomileusis (LASIK) with autologous platelet-rich plasma. J Refract Surg, in press.
16. Harwig D, Harloff S, Liu L, Schlenke P, Wedel T, Geerling G: Epitheliotrophic capacity of a growth factor preparation produced from platelet concentrates on corneal epithelial cells: a potential agent for the treatment of ocular surface defects? Transfusion 2004;44:1724-1731.
17. World Medical Association: World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Nurs Ethics 2002;9:105-109.
18. Murube J, Benitez del Castillo JM, Chenzhuo L, Berta A, Rolando M: The Madrid triple classification of dry eye. Arch Soc Esp Oftalmol 2003;78:587-593.
19. Alió JL, Feinbaum C: Management of dry eye (ocular surface syndrome - OSS) after refractive surgery; in Garg A, Sheppard JD, Donnenfeld ED, Meyer D, Mehta CK (eds): Clinical Diagnosis and Management of Dry Eye and Ocular Surface Disorders (Xero-Dacryology). New Delhi, Jaypee Brothers, 2006, pp 198-226.
20. Cho P, Brown B: Review of the tear break-up time and a closer look at the tear break-up time of Hong Kong Chinese. Optom Vis Sci 1993;70:30-38.
21. Nelson JD, Wright JC: Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984;102:1049-1051.
22. Mainstone JC, Bruce AS, Golding TR: Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res 1996;15:653-661.
23. McMonnies CW, Chapman-Davies A: Assessment of conjunctival hyperemia in contact lens wearers. Am J Optom Physiol Opt 1987;64:246-250.
24. Baudouin C: The pathology of dry eye. Surv Ophthalmol 2001;45:211-220.
25. McDonald JE: Surface phenomena of the tear film. Am J Ophthalmol 1969;67:56-64.
26. Lemp MA: Report of the National Eye Institute/ Industry Workshop on Clinical Trials in Dry Eyes. CLAO J 1995;21:221-232.
27. Foulks GN: What is dry eye and what does it mean to the contact lens wearer? Eye Contact Lens 2003;29:96-100.
28. Pflugfelder SC, Wilhelmus KR, Osato MS, Matoba AY, Font RL: The autoimmune nature of aqueous tear deficiency. Ophthalmology 1986;93:1513-1517.
29. Foulks GN: The evolving treatment of dry eye. Ophthalmol Clin North Am 2003;16:29-35.
30. Mathers WD: Why the eye becomes dry: a cornea and lacrimal gland feedback model. CLAO J 2000;26:159-165.
31. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC: The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17:584-589.
32. Samarkos M, Moutsopoulos HM: Recent advances in the management of ocular complications of Sjögren's syndrome. Curr Allergy Asthma Rep 2005;5:327-332.
33. Pepose JS, Akata RF, Pflugfelder SC, Voigt W: Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome. Ophthalmology 1990;97:1599-1605.
34. Mahoney EJ: Sjögren's disease. Otolaryngol Clin North Am 2003;36:733-745.
35. Marsh P, Pflugfelder SC: Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology 1999;106:811-816.
36. Yang CQ, Sun W, Gu YS: A clinical study of the efficacy of topical corticosteroids on dry eye. J Zhejiang Univ Sci B 2006;7:675-678.
37. Sullivan DA, Wickham LA, Rocha EM, Kelleher RS, da Silveira LA, Toda I: Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland. Adv Exp Med Biol 1998;438:11-42.
38. Schaumberg DA, Buring JE, Sullivan DA, Dana MR: Hormone replacement therapy and dry eye syndrome. JAMA 2001;286:2114-2119.
39. Barney NP: Can hormone replacement therapy cause dry eye? Arch Ophthalmol 2002;120:641-642.